Selinexor Treatment of Refractory Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

May 26, 2015

Primary Completion Date

July 26, 2019

Study Completion Date

July 26, 2019

Conditions
Multiple Myeloma
Interventions
DRUG

Selinexor

Fixed oral dose of 80 mg twice weekly (e.g., Monday and Wednesday or Tuesday and Thursday, etc.)

DRUG

Dexamethasone

20 mg was given with each dose of Selinexor.

Trial Locations (61)

1000

Jules Bordet Institute, Brussels

10016

NYU Perlmutter Cancer Center, New York

10029

Mt Sinai NYC, New York

10032

Columbia University, New York

11528

National & Kapodistrain University of Athens School of Medicine, Alexandra Hospital, Athens

14203

Roswell Park Cancer Institute, Buffalo

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

21287

Johns Hopkins Medicine, Baltimore

27514

UNC-Chapel Hill, Chapel Hill

30322

Emory University / Winship Cancer Institute, Atlanta

30342

Northside Hospital, Atlanta

32608

University of Florida Health Cancer Center- Shands Cancer Center Hospital, Gainesville

33136

Sylvester, University of Miami, Miami

33612

H. Lee Moffitt Cancer Center Research Institute, Tampa

35294

University of Alabama, Birmingham

37232

Vanderbilt University Ingram Cancer Center, Nashville

40202

Norton Cancer Institute, Louisville

44093

Nantes University Hospital Center, Nantes

44718

Gabrail Cancer Center, Canton

46202

Indiana University Simon Cancer Center, Indianapolis

48109

University of Michigan, Ann Arbor

48201

Karmanos Cancer Institute / Wayne State University, Detroit

52242

University of Iowa Hospitals & Clinics, Iowa City

54000

Brabois Adults Hospital, Nancy

55122

Universitätsmedizin Mainz, Mainz

55905

Mayo Clinic Rochester, Rochester

59037

Claude Huriez Hospital, Department of Blood Diseases, Lille

60637

University of Chicago Medicine, Chicago

63110

Washington University St. Louis, St Louis

66421

Universitätsklinikum des Saarlandes Klinik für Innere Medizin I, Homburg

69002

South Lyon Hospital Center, Department of Clinical Hematology, Lyon

69120

Universitätsklinikum Heidelberg Medizinische Klinik V, Heidelberg

75012

Hopital Saint-Antoine, Service d´Hematologie Clinique et Therapie Cellulaire, Paris

75013

La Pitie-Salpetriere University Hospital, Department of Clinical Hematology, Paris

75015

Necker Children's Hospital, Paris

75246

Baylor Sammons Cancer Center, Dallas

85259

Mayo Clinic (AZ), Scottsdale

90095

Jonnsson Comprehensive Cancer Center / University of Los Angeles, Los Angeles

91010

City of Hope, Duarte

96819

Kaiser Permanente- Hawaii, Honolulu

98109

Swedish Cancer Institute, Seattle

06510

Smilow Cancer Hospital, New Haven

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02215

Dana Farber Cancer Institute, Boston

07601

Hackensack University Medical Center / John Therurer Cancer Center, Hackensack

07652

Valley Hospital, Paramus

Unknown

Kaiser Permanente Northwest OR, Portland

University Hospital Krems, Department of Internal Medicine II, Krems

Salzburg Regional Hospital Müllner, Salzburg

Medical University Vienna, Department of Internal Medicine I, Vienna

ZNA Stuivenberg, Antwerp

General Hospital Saint-Jan, Bruges

University Hospital Ghent, Ghent

University Hospital Leuven, Campus Gasthuisberg, Leuven

University hospital of Tuebingen, Internal Medicine II, Tübingen

Med. Klinik und Poliklinik II Universitätsklinikum, Würzburg

B-1200

UCL Saint-Luc, Brussels

B-5530

UCL Mont-Godinne, Yvoir

01307

BAG Oncology Gemeinschaftspraxis, Dresden

D-79106

University Hospital Freiburg, Department of Internal Medicine I, Freiburg im Breisgau

Sponsors
All Listed Sponsors
lead

Karyopharm Therapeutics Inc

INDUSTRY